Postmortem femoral blood concentrations of amlodipine

Journal of Analytical Toxicology

Volumn 35, Issue 4, 2011, Pages 227-231

  Linnet, Kristian ^a   Lang, Lotte Markussen ^a   Johansen, Sys Stybe ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CITALOPRAM; CYTOCHROME P450 3A4; DILTIAZEM; FLUCONAZOLE; MIRTAZAPINE; OXAZEPAM; VENLAFAXINE;

ADULT; AGED; ARTICLE; AUTOPSY; CAUSE OF DEATH; DEPRESSION; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; TANDEM MASS SPECTROMETRY;

EID: 79954603216     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/anatox/35.4.227     Document Type: Article

References (23)

1. D.R. Abernethy. The pharmacokinetic profile of amlodipine. Am. Heart J. 118: 1100-1103 (1989).
2. S.Vogt, A. Mehlig, P. Hunziker, A. Scholer, J. Jung, A.B. Gonzalez, W. Weinmann, and S. Marsch. Survival of severe amlodipine intoxication due to medical intensive care. Forensic Sci. Int. 161: 216-220 (2006).
3. S.H. Cosbey and D.J. Carson. A fatal case of amlodipine poisoning. J. Anal. Toxicol. 21: 221-222 (1997).
4. J.H. Sklerov, B. Levine, K.M. Ingwersen, P.A. Aronica-Pollack, and D. Fowler. Two cases of fatal amlodipine overdose. J. Anal. Toxicol. 74: 165-73 (2006).
5. R.W. Prouty and W.H. Anderson. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J. Forensic Sci. 35: 243-270 (1990).
6. D.J. Pounder and G.R. Jones. Post-mortem drug redistribution- a toxicological nightmare. Forensic Sci. Int. 45: 253-263 (1990).
7. H. Druid and P. Holmgren. A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J. Forensic Sci. 42: 79-87 (1997).
8. M. Reis, T. Aamo, J. Ahlner, and H. Druid. Reference concentrations of antidepressants. A compilation of postmortem and therapeutic levels. J. Anal. Toxicol. 31: 254-264 (2007).
9. C. Vance and I.M. McIntyre. Postmortem tissue concentrations of olanzapine. J. Anal. Toxicol. 33: 15-26 (2009).
10. D.R. Parker and I.M. McIntyre. Case studies of postmortem quetiapine: therapeutic or toxic concentrations? J. Anal. Toxicol. 29: 407-412 (2005).
11. S.S. Johansen and J. Genner. A fatal case of amlodipine poisoning. J. Clin. Forensic Med. 10: 169-172 (2003).
12. D.M. Williams and L. Cubeddu. Amlodipine pharmacokinetics in healthy volunteers. J. Clin. Pharm. 28: 990-994 (1988).
13. J.K. Faulkner, D. McGibney, L.F. Chasseaud, J.L. Perry, and I.W. Taylor. The pharmacokinetics of amlodipine in healthy volunteers after single intraveneous and oral doses and after 14 repeated oral doses given once daily. Br. J. Clin. Pharm. 22: 21-25 (1986).
14. G. Lehmann, G. Reiniger, A. Beyerle, andW. Rudolph. Pharmacokinetics and additional anti-ischaemic effectiveness of amlodipine, a once-daily calcium antagonist, during acute and longterm therapy of stable angina pectoris in patients pre-treated with a beta-blocker. Eur. Heart J. 14: 1531-1535 (1993).
15. E.J. Stanek, C.E. Nelson, and D. DeNofrio. Amlodipine overdose. Ann. Pharmacother. 31: 853-856 (1997).
16. B.D. Adams andW.T. Browne. Amlodipine overdose causes prolonged calcium channel blocker toxicity. Am. J. Emerg.Med. 16: 527-528 (1998).
17. R.P. Poggenborg, L. Videbaek, and I.A. Jacobsen. A case of amlodipine overdose. Basic Clin. Pharm. Tox. 99: 209-212 (2006).
18. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 8th ed. Biomedical Publications, Foster City, CA, 2008, pp 74-75.
19. M. Schulz and A. Schmoldt. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58: 447-474 (2003).
20. Reference blood level list of therapeutic and toxic substances, http://www.tiaft.org/tmembers/ttv/ttv_all.php (TIAFT membership required for access).
21. Y. Nivoix, D. Levêque, R. Herbrecht, J.C. Koffel, L. Beretz, and G. Ubeaud-Sequier. The enzymatic basis of drug-drug interactions with systemic triazole antifungals. Clin. Pharmacokinet. 47: 779-92 (2008).
22. B. Ma, T. Prueksaritanont, and J.H. Lin. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab. Dispos. 28: 125-130 (2000).
23. L. Ni, X. Yu, Q. Yu, X. Chen, and L. Jia. Effects of cyclosporine A and itraconazole on permeability, biliary excretion and pharmacokinetics of amlodipine. Drug Metab. Lett. 2: 163-168 (2008).